VYGR - Voyager Therapeutics, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 4.95

Open

$ 5.21

Bid

$ 4.90 x 10

Ask

$ 5.33 x 42

Day's Range

$ 4.95 - $ 5.27

52 Week Range

$ 2.65 - $ 8.28

Volume

494,345

Average Volume

Market Cap

274.57M

Beta (5Y Monthly)

$ 1.19

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2025	06-30-2025	10-Q
2	05-06-2025	03-31-2025	10-Q
3	03-11-2025	12-31-2024	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-06-2024	06-30-2024	10-Q
6	05-13-2024	03-31-2024	10-Q
7	02-28-2024	12-31-2023	10-K
8	11-06-2023	09-30-2023	10-Q
9	08-03-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-07-2023	12-31-2022	10-K
12	11-08-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-04-2022	03-31-2022	10-Q
15	03-08-2022	12-31-2021	10-K
16	11-02-2021	09-30-2021	10-Q
17	08-09-2021	06-30-2021	10-Q
18	05-10-2021	03-31-2021	10-Q
19	02-25-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-10-2020	06-30-2020	10-Q
22	05-06-2020	03-31-2020	10-Q
23	03-03-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-09-2019	06-30-2019	10-Q
26	05-07-2019	03-31-2019	10-Q
27	02-26-2019	12-31-2018	10-K
28	11-07-2018	09-30-2018	10-Q
29	08-07-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-14-2018	12-31-2017	10-K
32	11-02-2017	09-30-2017	10-Q
33	08-08-2017	06-30-2017	10-Q
34	05-09-2017	03-31-2017	10-Q
35	03-15-2017	12-31-2016	10-K
36	11-10-2016	09-30-2016	10-Q
37	08-11-2016	06-30-2016	10-Q
38	05-12-2016	03-31-2016	10-Q
39	03-17-2016	12-31-2015	10-K
40	12-17-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Tuesday's ...
09/30/2025 21:06:48

voyager-therapeutics-alzheimers-portfolio-and-alpl-neuroshuttle-underscore-platform-momentum-analyst

Voyager Therapeutics Alzheimer's Portfolio...
09/15/2025 18:00:31

Voyager's Alzheimer's programs show longer CNS exposure and potential gene therapy advances, with analysts maintaining ...

HC Wainwright & Co. Reiterates Buy on Voya...
09/15/2025 11:11:51

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $...

Wedbush Maintains Outperform on Voyager Th...
08/07/2025 12:43:09

Wedbush analyst Yun Zhong maintains Voyager Therapeutics (NASDAQ:VYGR) with a Outperform and lowers the price target from $9...

Voyager Therapeutics Q2 EPS $(0.57) Misses...
08/06/2025 20:52:23

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate o...

Voyager Therapeutics Introduced A Wholly-O...
07/16/2025 11:02:20

New program combines IV-delivered TRACER capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 va...

CORRECTION: Voyager Technologies Ticker Is...
06/12/2025 18:49:20

Voyager Therapeutics Announces First Peer-...
05/15/2025 11:07:08

Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseas...

12 Health Care Stocks Moving In Friday's A...
05/09/2025 21:06:23

Voyager Therapeutics Q1 EPS $(0.53) Misses...
05/06/2025 20:42:00

Voyager Therapeutics (NASDAQ:VYGR) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate o...

7 Analysts Assess Voyager Therapeutics: Wh...
04/08/2025 18:01:01

HC Wainwright & Co. Reiterates Buy on Voya...
04/08/2025 17:36:21

HC Wainwright & Co. analyst Patrick Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $30 ...

Voyager Unveils Preclinical Data On Dual T...
03/31/2025 11:24:03

- Single IV administration of tau silencing gene therapy VY1706 significantly reduced tau mRNA and protein levels, with broad b...

Canaccord Genuity Maintains Buy on Voyager...
03/13/2025 16:15:46

Canaccord Genuity analyst Sumant Kulkarni maintains Voyager Therapeutics (NASDAQ:VYGR) with a Buy and lowers the price targe...

HC Wainwright & Co. Reiterates Buy on Voya...
03/13/2025 10:18:10

HC Wainwright & Co. analyst Patrick Trucchio reiterates Voyager Therapeutics (NASDAQ:VYGR) with a Buy and maintains $30 ...

A Glimpse Into The Expert Outlook On Voyag...
03/12/2025 21:04:11

Wells Fargo Maintains Overweight on Voyage...
03/12/2025 15:27:41

Wells Fargo analyst Yanan Zhu maintains Voyager Therapeutics (NASDAQ:VYGR) with a Overweight and lowers the price target fro...

Wedbush Reiterates Outperform on Voyager T...
03/12/2025 14:28:42

Wedbush analyst Yun Zhong reiterates Voyager Therapeutics (NASDAQ:VYGR) from Outperform to Outperform.

Cantor Fitzgerald Reiterates Overweight on...
03/12/2025 14:11:05

Cantor Fitzgerald analyst Pete Stavropoulos reiterates Voyager Therapeutics (NASDAQ:VYGR) from Overweight to Overweight.

Voyager Therapeutics Says We Expect Our Ca...
03/11/2025 20:05:27